115
Participants
Start Date
February 10, 2006
Primary Completion Date
August 22, 2006
Study Completion Date
September 9, 2006
Sugammadex
Single bolus intravenous (IV) dose of 16.0 mg/kg sugammadex
Succinylcholine
Single bolus IV dose of 1.0 mg/kg succinylcholine
Rocuronium
Single bolus IV dose of 1.2 mg/kg rocuronium
Merck Sharp & Dohme LLC
INDUSTRY